Shots:
Health Canada has approved Nexsphere-F for the treatment of musculoskeletal pain embolization
Nexsphere-F has launched the pivotal RESORB trial in the US post-IDE approval in 126 knee osteoarthritis pts comparing genicular artery embolization vs corticosteroid injections, with enrollment expected to complete in H1’26
Nexsphere-F uses resorbable microsphere tech to temporarily block abnormal blood flow…
